Episode Summary

Europe has the science. The talent. The breakthroughs.But when an idea feels too uncertain, our systems shut it down before it has a chance to breathe.And with every safe bet… we quietly lose the next cure, the next Car-T, the next AI that could change everything. 🚨 Risk-aversion, fragmentation, and bureaucracy are draining Europe’s innovation power—and nobody dares to name it out loud.But Fabrizio Conicella, VP of Open Innovation at Chiesi Group, isn’t holding back. 💡 In this deep, urgent conversation, Fabrizio shares how Europe can build the ecosystems we need to turn bold ideas into real-world impact—without compromising ethics, patients, or long-term value. 🎧 Watch now to explore: 1️⃣ Why uncertainty, not risk, is the true frontier of innovation 2️⃣ The hidden reasons startups leave Europe—and how to keep them 3️⃣ How Chiesi’s “The Impulse” model flips corporate R&D on its head 4️⃣ What every policymaker, CEO, and scientist must change before it’s too late 5️⃣ A bold new playbook for turning visionary science into trusted medicine 👤 About Fabrizio Conicella: As one of Europe’s leading voices in health innovation, Fabrizio is pioneering how pharma collaborates across startups, data, and ethics. His mission: create environments where the best ideas don’t get shut down—they get built. 💬 Quotes That Might Just Change Your Thinking: (01:58:01) "Be bold enough to dream, but pragmatic enough to make it real." (01:07:22) "Science is essential, but turning it into a product requires a different kind of wisdom." (01:04:35) "Visionary entrepreneurs see the future and change the game." (00:16:51) "Innovation today is no longer a race for ownership, but a journey of collaboration." (00:47:55) "If the idea is truly bold, no pharma company can replicate it without you." ⏱️ Timestamps: (03:00) Europe’s Innovation Crisis: A Wake-Up Call (08:19) Chiesi’s Bold B Corp Strategy (16:26) Building Healthcare Innovation Ecosystems (22:09) Predictive Medicine and Patient Data (29:49) Pharma vs. Startup Ecosystems Today (34:38) Why R&D Must Go External (35:06) The End of Buy-and-Wait Pharma (41:42) Ethics First: Pharma’s New Mandate (44:06) Respecting Founders, Not Just IP (47:23) Debunking the 'Pharma Steals Ideas' Myth (54:10) Why Pharma Moves Slowly—but Must Adapt (59:25) Market Acumen: Startups’ Missing Ingredient (01:04:35) What Makes a Visionary Entrepreneur (01:29:22) Embracing Failure to Spark Innovation (01:46:01) Europe’s Risk Culture is Holding Us Back 🔔 Help Us Grow the Future of Thoughtful Innovation If this conversation sparked something in you—an insight, a question, a sense of urgency—help us keep it alive. Subscribe. Leave a comment. Share it with someone who still believes bold ideas deserve a fighting chance. Every action brings in deeper minds, bigger questions, and the kind of leadership our systems so desperately need. Book mention: The Venture Mindset🎧 Watch now—and join the movement to rebuild Europe’s innovation edge.Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the
... Show More



    No results